Virtus LifeSci Biotech Products ETF (BBP) Short Interest Ratio & Short Volume

Short interest is the volume of Virtus LifeSci Biotech Products ETF shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 6,800 shares of BBP short. Learn More on Virtus LifeSci Biotech Products ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BBP shares currently have a short interest ratio of 2.0. Learn More on Virtus LifeSci Biotech Products ETF's short interest ratio.

Virtus LifeSci Biotech Products ETF saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 6,800 shares, an increase of 871.4% from the previous total of 700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Virtus LifeSci Biotech Products ETF: First Trust Nasdaq Pharmaceuticals ETF (2.18%), Harbor Health Care ETF (0.20%), Virtus LifeSci Biotech Clinical Trials ETF (9.56%), Direxion Daily Pharmaceutical & Medical Bull 3X Shares (2.70%), Invesco Nasdaq Biotechnology ETF (0.32%), JPMorgan Healthcare Leaders ETF (0.07%), Langar Global HealthTech ETF (0.62%), ProShares UltraShort Nasdaq Biotechnology (5.59%), ProShares UltraShort Health Care (35.62%), ProShares Ultra Nasdaq Biotechnology (1.82%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

Short selling BBP is an investing strategy that aims to generate trading profit from Virtus LifeSci Biotech Products ETF as its price is falling. BBP shares are trading up $1.74 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Virtus LifeSci Biotech Products ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BBP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBP, twice per month. The most recent reporting period available is May, 15 2025.